Brief: Keros Therapeutics Completes Enrollment Of Tropos Phase 2 Trial
30/09/2024 13:38
Sept 30 (Reuters) - Keros Therapeutics Inc KROS.O :
* KEROS THERAPEUTICS : COMPLETES ENROLLMENT OF TROPOS PHASE
2
TRIAL
* KEROS THERAPEUTICS: TO PRESENT TOPLINE DATA IN Q2 2025
Further company coverage: KROS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops